20 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

• Medigus, Inc. MDGS stock moved upwards by 70.21% to $4 during Friday's pre-market session.

• Genetic Technologies, Inc. GENE shares increased by 17.65% to $2.20.

• Akorn, Inc. AKRX shares increased by 13.76% to $0.24.

• Tonix Pharmaceuticals, Inc. TNXP shares moved upwards by 12.59% to $0.76.

• Innovate, Inc. INNT shares moved upwards by 11.11% to $0.78.

• Akari Therapeutics, Inc. AKTX shares rose 10.94% to $2.13. The most recent rating by B. Riley FBR, on Mar 13, is at Buy, with a price target of $5.

• Co-Diagnostics, Inc. CODX shares moved upwards by 10.23% to $12.50. According to the most recent rating by Maxim Group, on Mar 3, the current rating is at Hold.

• Athersys, Inc. ATHX shares moved upwards by 6.52% to $2.45.

• Salarius Pharmaceuticals, Inc. SLRX stock increased by 4.81% to $0.87. According to the most recent rating by Ladenburg Thalmann, on Apr 27, the current rating is at Buy.

• Guardion Health Sciences, Inc. GHSI shares rose 4.22% to $0.48.

Losers

• Second Sight Medical, Inc. EYES shares decreased by 12.03% to $1.17 during Friday's pre-market session.

• Milestone Pharmaceuticals, Inc. MIST shares decreased by 6.98% to $2.80. According to the most recent rating by Jefferies, on Mar 25, the current rating is at Hold.

• Capricor Therapeutics, Inc. CAPR shares fell 6.86% to $6.52.

• ThermoGenesis Holdings, Inc. THMO shares fell 6.18% to $10.78. The most recent rating by H.C. Wainwright, on Apr 17, is at Buy, with a price target of $10.

• Luminex, Inc. LMNX shares fell 5.55% to $34.05.

• Gilead Sciences, Inc. GILD stock declined 5.36% to $79.50. According to the most recent rating by JP Morgan, on May 1, the current rating is at Neutral.

• Tilray, Inc. TLRY shares fell 5.34% to $7.62. The most recent rating by Jefferies, on Apr 16, is at Underperform, with a price target of $5.

• SmileDirectClub, Inc. SDC shares declined 4.92% to $7.34. The most recent rating by UBS, on Mar 2, is at Neutral, with a price target of $9.

• Sunesis Pharmaceuticals, Inc. SNSS shares declined 4.47% to $0.43. The most recent rating by H.C. Wainwright, on Mar 11, is at Neutral, with a price target of $1.

• Sientra, Inc. SIEN shares decreased by 3.91% to $2.21. The most recent rating by Stephens & Co., on Mar 23, is at Overweight, with a price target of $5.